 The European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has adopted a positive opinion for GW Pharmaceuticals Plcs NASDAQ: GWPH Epidyolex cannabidiol. It is an adjunctive treatment of seizures associated with Tuberous Sclerosis Complex TSC for patients two years of age and older. 